Use of unnecessary medications by patients with advanced cancer: Cross-sectional survey

Supportive Care in Cancer

Volumn 19, Issue 9, 2011, Pages 1313-1318

  Fede, Angelo ^a   Miranda, Michele ^a   Antonangelo, Daniella ^a   Trevizan, Ligia ^a   Schaffhausser, Henrique ^a   Hamermesz, Bruno ^a   Zimmermann, Camile ^a   Del Giglio, Auro ^a   Riechelmann, Rachel P ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Medical futility; Medication errors; Neoplasms

Indexed keywords

ANTACID AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM; CAPTOPRIL; DIPYRONE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OPIATE; PARACETAMOL; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ADVANCED CANCER; ARTICLE; BRAZIL; CANCER PATIENT; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION; PRIORITY JOURNAL; UNECESSARY MEDICATION;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION RECONCILIATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TERMINAL CARE; TERMINALLY ILL;

EID: 80051596558     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0947-1     Document Type: Article

References (25)

1. A Halevy BA Brody 1999 Medical futility in end-of-life care JAMA 282 14 1331 1332 10527175 10.1001/jama.282.14.1331 1:STN:280:DyaK1MvlsVaquw%3D%3D (Pubitemid 29483186)
2. HP Honegger 1991 Avoiding futility: assessment of cancer patients in intensive care units Ann Oncol 2 8 530 531 1793718 1:STN:280: DyaK387nt1Oktg%3D%3D
3. VE von Gruenigen BJ Daly 2005 Futility: clinical decisions at the end-of-life in women with ovarian cancer Gynecol Oncol 97 2 638 644 10.1016/j.ygyno.2005.01.031 (Pubitemid 40614915)
4. NS Jecker RA Pearlman 1992 Medical futility. Who decides? Arch Intern Med 152 6 1140 1144 1599340 10.1001/archinte.152.6.1140 1:STN:280: DyaK383os1ykuw%3D%3D
5. RA Burt 2002 The medical futility debate: patient choice, physician obligation, and end-of-life care J Palliat Med 5 2 249 254 12006225 10.1089/109662102753641223 (Pubitemid 34275021)
6. MD Cantor CH Braddock 3rd AR Derse, et al. 2003 Do-not-resuscitate orders and medical futility Arch Intern Med 163 22 2689 2694 14662622 10.1001/archinte.163.22.2689 (Pubitemid 37517409)
7. DL Kasman 2004 When is medical treatment futile? A guide for students, residents, and physicians J Gen Intern Med 19 10 1053 1056 15482559 10.1111/j.1525-1497.2004.40134.x (Pubitemid 39431143)
8. J Khatcheressian SB Harrington LJ Lyckholm TJ Smith 2008 'Futile care': what to do when your patient insists on chemotherapy that likely won't help Oncology (Williston Park) 22 8 881 888 discussion 893, 896, 898
9. RP Riechelmann MK Krzyzanowska C Zimmermann 2009 Futile medication use in terminally ill cancer patients Support Care Cancer 17 6 745 748 19030900 10.1007/s00520-008-0541-y
10. RP Riechelmann MK Krzyzanowska A O'Carroll C Zimmermann 2007 Symptom and medication profiles among cancer patients attending a palliative care clinic Support Care Cancer 15 12 1407 1412 17429699 10.1007/s00520-007-0253-8 (Pubitemid 350077220)
11. DC Currow JP Stevenson AP Abernethy J Plummer TM Shelby-James 2007 Prescribing in palliative care as death approaches J Am Geriatr Soc 55 4 590 595 17397439 10.1111/j.1532-5415.2007.01124.x (Pubitemid 46496589)
12. RP Riechelmann C Zimmermann SN Chin, et al. 2008 Potential drug interactions in cancer patients receiving supportive care exclusively J Pain Symptom Manage 35 5 535 543 18243638 10.1016/j.jpainsymman.2007.06.009
13. ME Corcoran 1997 Polypharmacy in the older patient with cancer Cancer Control 4 5 419 428 10763050 (Pubitemid 27461553)
14. RP Riechelmann A Del Giglio 2009 Drug interactions in oncology: how common are they? Ann Oncol 20 1907 1912 19713244 10.1093/annonc/mdp369 1:STN:280:DC%2BD1Mjnt1WktA%3D%3D
15. P Glare K Virik M Jones, et al. 2003 A systematic review of physicians' survival predictions in terminally ill cancer patients BMJ 327 7408 195 198 12881260 10.1136/bmj.327.7408.195 (Pubitemid 36920584)
16. MM Oken RH Creech DC Tormey, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 6 649 655 7165009 10.1097/00000421-198212000-00014 1:STN:280:DyaL3s7kvFOgsw%3D%3D (Pubitemid 13149996)
17. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D (Pubitemid 17055592)
18. EB Curtis TD Walsh 1993 Prescribing practices of a palliative care service J Pain Symptom Manage 8 5 312 316 7525747 10.1016/0885-3924(93)90160-W 1:STN:280:DyaK2M%2Flt12jsw%3D%3D (Pubitemid 23191395)
19. S Mercadante F Fulfaro A Casuccio 2001 Pattern of drug use by advanced cancer patients followed at home J Palliat Care 17 1 37 40 11324183 1:STN:280:DC%2BD3M3ntFWntw%3D%3D (Pubitemid 33710834)
20. F Nauck C Ostgathe E Klaschik, et al. 2004 Drugs in palliative care: results from a representative survey in Germany Palliat Med 18 2 100 107 15046406 10.1191/0269216304pm852oa (Pubitemid 38380026)
21. Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J. (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. The International Journal of Pharmacy Practice (September issue):71
22. S Kite S Wilkinson 2002 Beyond futility: to what extent is the concept of futility useful in clinical decision-making about CPR? Lancet Oncol 3 10 638 642 12372726 10.1016/S1470-2045(02)00878-1 (Pubitemid 35174682)
23. AM Vollrath C Sinclair J Hallenbeck 2005 Discontinuing cardiovascular medications at the end of life: lipid-lowering agents J Palliat Med 8 4 876 881 16128666 10.1089/jpm.2005.8.876 (Pubitemid 41266265)
24. ES Samano LM Ribeiro AS Campos, et al. 2005 Use of complementary and alternative medicine by Brazilian oncologists Eur J Cancer Care (Engl) 14 2 143 148 10.1111/j.1365-2354.2005.00524.x 1:STN:280:DC%2BD2M3gvVyiug%3D%3D (Pubitemid 40655731)
25. TK Basu 1985 Drug-vitamin interaction Int J Vitam Nutr Res Suppl 27 247 258 3926698 1:CAS:528:DyaL2MXltFGnu7w%3D